Modern healthcare professionals are exploring the depths of the technology facets of pharmaceutical solutions to open more avenues for immunotherapy innovations. The rise of immunotherapy is opening up treatment options for a growing number of previously incurable diseases and is completely transforming oncology care. Instilled with state-of-the-art technologies such as IoT, artificial intelligence (AI) and big data, finding new ways of identifying patients most likely to respond to specific immunotherapeutic approaches is now a primary focus. Moreover, the pursuit of exploring new ways of healthcare has led to a precise medication that can address a wide range of challenges related to cell therapy.
The Immunotherapy Drugs Market was valued at USD 164.68 billion in 2020 and is expected to reach USD 276.51 billion by 2026, registering a CAGR of 8.41% during the forecast period. The major factors attributing to this growth of the immunotherapy drugs market are the emergence of biosimilars, the rising adoption of targeted therapy over traditional therapy and a growing prevalence of chronic diseases and lifestyle disorders. In addition, the impact of COVID-19 on the immunotherapy drugs market is also positive because many companies are currently focused on developing immunotherapy-based drugs or vaccines for COVID-19. Moreover, the need for process efficiency and cost-effectiveness is engaging widespread automation efforts in cell therapy fields. Furthermore, factors such as growing research collaborations and emerging direct and indirect investments in research and development (R&D) by pharmaceutical and biotechnology companies are also supporting the market’s growth in the coming years.
At this juncture, there is a wide range of immunotherapy companies entering the market with a set of innovative immunotherapy solutions. To help leaders navigate through the list of immunotherapy solutions providers, Pharma Tech Outlook’s editorial board has narrowed down the top solutions providers in the landscape that are transforming immunotherapy treatments. Besides, the magazine also contains insights, best practices and advice for the aspiring CXOs. We present to you Pharma Tech Outlook’s “Top 10 Immunotherapy Solutions Providers - 2022.”
